Medtronic has received CE-mark approval for the Endurant stent graft system to remove a ruptured abdominal aortic aneurysm (rAAA) treatment warning, the company shared in a press release this week. The labelling update follows the US Food and Drug Administration (FDA) labelling approval received in October 2025. “When a patient presents with a ruptured abdominal […] The post Medtronic’s Endurant stent graft system receives CE mark for updated rupture labelling appeared first on Cardiovascular News .